RTL
THRX

Red Tortoise LLC’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Red Tortoise LLC’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-536
Closed -$1.44K – 603
2023
Q3 		$1.44K Buy
+536
New +$2.1K ﹤0.01% 509

Other funds holding THRX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Red Tortoise LLC's THRX Position: Q4 2023 in Review

Red Tortoise LLC sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 536 shares — an estimated $1.44K sold.

Red Tortoise LLC first reported a position in THRX in Q3 2023 and held it in 1 quarter. The position peaked at $1.44K in Q3 2023. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Red Tortoise LLC reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Red Tortoise LLC sold 536 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $1.44K.
  • Red Tortoise LLC first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Red Tortoise LLC's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $1.44K in Q3 2023.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Red Tortoise LLC's 13F filing for Q4 2023, filed 31 Jan 2024.